510(k) Report

510(k) · Cleared

Cleared

Droplet Pen Needles

K143437510(k) TraditionalCleared Jun 25, 2015206-day reviewClass II21 CFR 880.5570

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Htl-Strefa S.A · FMI Needle, Hypodermic, Single Lumen

Cleared on Jun 25, 2015 as substantially equivalent to K031200 (Becton, Dickinson & CO, 2003) and 1 other predicate after a 206-day review. Its family tree reaches back 2 generations to 2005. 4 later devices descend from it.

Decided
Jun 25, 2015
Review
206 days
Class
Class II
Product code
FMI
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K051899 (2005). 3 ancestors in all, the oldest K031200 (2003). 4 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2003: 1 other ancestor2018: 1 descendant cleared2020: 1 descendant cleared2023: 1 descendant cleared2026: 1 descendant clearedReference device: K133738 · Novofine Plus 32G 4 MM · Novo Nordisk, Inc. · 2014Reference device: K013782 · Disetronic Penfine Insulin Injection Pen Needle · Disetronic Medical Systems · 2001K051899 · BD Pen Needle · Becton, Dickinson & CO · 2005K100005 · BD Pen Needle · Becton, Dickinson and Co. · 2010200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant2 generations forward: 3 descendants K100005 · BD Pen Needle · Becton, Dickinson and Co. · 2010K051899 · BD Pen Needle · Becton, Dickinson & CO · 20050
  1. Root · 2 generations backK051899 BD Pen NeedleBecton, Dickinson & CO · 2005
  2. 1 generation backK100005 BD Pen NeedleBecton, Dickinson and Co. · 2010
  3. This deviceK143437 Droplet Pen NeedlesHtl-Strefa S.A · 2015
  4. Descendant · cites it directly · 3 of its ownK171982 Droplet Pen NeedleHtl-Strefa S.A · 2018
  5. Descendant · 2 generations on · 0 of its ownK260739 Profoject™ Pen Needles (Model A; Model B)CMT Health PTE., Ltd. · 2026
  6. Descendant · 2 generations on · 0 of its ownK230635 Pen NeedleJiangsu Caina Medical Co.,Ltd · 2023
  7. Descendant · 2 generations on · 0 of its ownK192464 Injection Pen NeedleGangan Medical Technology Jiangsu Co., Ltd. · 2020

Most influential descendants

Showing 4 of 4 · See all
  • K171982Droplet Pen NeedleHtl-Strefa S.A · 2018 · cites it directly3descendants
  • K260739Profoject™ Pen Needles (Model A; Model B)CMT Health PTE., Ltd. · 2026 · 2 generations on0descendants
  • K230635Pen NeedleJiangsu Caina Medical Co.,Ltd · 2023 · 2 generations on0descendants
  • K192464Injection Pen NeedleGangan Medical Technology Jiangsu Co., Ltd. · 2020 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K051899BD Pen NeedleBecton, Dickinson & CO2005—
−1K100005BD Pen NeedleBecton, Dickinson and Co.2010—
0 (this device)K143437Droplet Pen NeedlesHtl-Strefa S.A2015—
+1K171982Droplet Pen NeedleHtl-Strefa S.A2018—
+2K260739Profoject™ Pen Needles (Model A; Model B)CMT Health PTE., Ltd.2026—
+2K230635Pen NeedleJiangsu Caina Medical Co.,Ltd2023—
+2K192464Injection Pen NeedleGangan Medical Technology Jiangsu Co., Ltd.2020—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201810
202010
202310
202610
FIG. 1 — Lineage of K143437, 2005–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FMI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FMI device

  1. #1 K252886 Pen Needlescore 14.5 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K031200Modification to BD Ultra-Fine Iii Pen Needle
Summary page 4
…antial equivalence is claimed are: Manufacturer Trade Name 510(k) Number Becton Dickson & Co. BD Ultra-Fine K031200 Becton Dickson & Co. BD Ultra-Fine K100005 Reference devices: Manufacturer Trade…
Becton, Dickinson & CO2003—
*K100005BD Pen Needle
Summary page 4
…Trade Name 510(k) Number Becton Dickson & Co. BD Ultra-Fine K031200 Becton Dickson & Co. BD Ultra-Fine K100005 Reference devices: Manufacturer Trade Name 510(k) Number Novo Nordisk Inc.…
Becton, Dickinson and Co.2010—
†K133738Novofine Plus 32G 4 MMNovo Nordisk, Inc.2014—
†K013782Disetronic Penfine Insulin Injection Pen NeedleDisetronic Medical Systems2001—

Also cleared against K031200: 2 other devices →

What descends from it? (4)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K171982Droplet Pen NeedleHtl-Strefa S.A20183

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 10 years and passes through 3 companies; a new generation was cleared every 5.2 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K171982 (Htl-Strefa S.A, 2018) has gone furthest, with 3 descendants of its own.
  • 2 other devices also cite its predicate K031200.

How does its category compare?

All FMI devices

FMI Needle, Hypodermic, Single Lumen: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · FMI

11in 2025

2007: 152008: 102009: 72010: 152011: 122012: 172013: 112014: 142015: 102016: 202017: 92018: 202019: 122020: 112021: 182022: 232023: 182024: 32025: 112026 (partial year): 12
2007high 23 (2022) · low 3 (2024)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FMI

141in 2025

2007: 71 days median2008: 85 days median2009: 177 days median2010: 119 days median2011: 113 days median2012: 107 days median2013: 87 days median2014: 155 days median2015: 89 days median2016: 217 days median2017: 253 days median2018: 176 days median2019: 186 days median2020: 263 days median2021: 143 days median2022: 189 days median2023: 112 days median2024: 90 days median2025: 141 days median2026 (partial year): 119 days median
2007high 263 (2020) · low 71 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FMI

1in 2024

2007: 22008: 42009: 32010: 792011: 52012: 12013: 12014: 32015: 12017: 162019: 52020: 32021: 72023: 22024: 12026 (partial year): 1, 1 Class I
2007high 79 (2010) · low 0 (2016)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · FMI

2,424in 2025

2007: 2082008: 1772009: 2632010: 2492011: 2402012: 2152013: 2552014: 2872015: 5672016: 9412017: 1,5472018: 2,3982019: 4,8962020: 4,2452021: 4,5322022: 4,8852023: 4,9862024: 4,0532025: 2,424
2007high 4,986 (2023) · low 177 (2008)2025

MAUDE reports naming product code FMI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200715712208
200810854177
200971773263
20101511979249
2011121135240
2012171071215
201311871255
2014141553287
201510891567
2016202170941
20179253161,547
20182017602,398
20191218654,896
20201126334,245
20211814374,532
20222318904,885
20231811224,986
202439014,053
20251114102,424
2026121191 (1)—

What is it indicated for?

The Droplet® Pen Needles are intended for use with pen injector device for the subcutaneous injection of insulin.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K143437: Droplet Pen Needles.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K143437

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026